rxrx: the income statement

MyFinsight

For the quarter ending 2025-09-30, RXRX made $5,175K in revenue. -$162,253K in net income. Net profit margin of -3135.32%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Total revenue	5,175	19,223	14,745	26,082
Cost of revenue	14,687	20,161	21,829	12,079
Research and development	121,062	128,636	129,634	74,600
General and administrative	41,628	46,653	54,650	37,757
Total operating costs and expenses	177,377	195,450	206,113	124,436
Loss from operations	-172,202	-176,227	-191,368	-98,354
Other income, net	9,952	4,330	-11,277	2,679
Loss before income tax benefit	-162,250	-171,897	-202,645	-95,675
Income tax benefit (expense)	3	0	-158	167
Net loss	-162,253	-171,897	-202,487	-95,842

Net loss per share of class a, b and exchangeable common stock, basic (in dollars per share)	-0.36	-0.41	-0.5	-0.34
Net loss per share of class a, b and exchangeable common stock, diluted (in dollars per share)	-0.36	-0.41	-0.5	-0.34
Weighted-average shares (class a, b and exchangeable) outstanding, basic (in shares)	446,988,046	417,361,147	402,771,972	282,583,048
Weighted-average shares (class a, b and exchangeable) outstanding, diluted (in shares)	446,988,046	417,361,147	402,771,972	282,583,048